American Psychiatric Association - www.psych.orgClinical Resources: Practice Guidelines

AAPEL
PSYCHOPHARMACOLOGICAL TREATMENT ALGORITHMS

text from the page
http://www.psych.org/clin_res/borderline.book-8.appendixes.cfm#appendixes
(all rights reserved)

All this information is from the American Psychiatric Association (Dec 2002)
It is important to verify the relevance of this information
The goal is to understand the medication process
Each patient need his her own treatment and need a clinical judgment before taking any drug
The duration of treatment is therefore a clinical judgment that depends on the patient’s clinical status and medication tolerance at any point in time

Practice Guideline for the Treatment of Patients With Borderline Personality Disorder
APPENDIXES:
PSYCHOPHARMACOLOGICAL TREATMENT ALGORITHMS

APPENDIX 1. Psychopharmacological Treatment
of Affective Dysregulation Symptoms
in Patients With Borderline Personality Disorder^a

^aAlgorithm based on clinical judgment that uses evidence currently in the literature, following the format of the International Psychopharmacology Algorithm Project (2). The first step in the algorithm is generally supported by the best empirical evidence. Recommendations may not be applicable to all patients or take individual needs into account. The empirical research studies on which these recommendations are based may be "first trials" involving previously untreated patients and may not take into account previous patient nonresponse to one, two, or even three levels of the algorithm (i.e., patients who, by definition, have more refractory disorders). There are no empirical trials of the complete algorithm.

APPENDIX 2. Psychopharmacological Treatment of
Impulsive-Behavioral Dyscontrol Symptoms in
Patients With Borderline Personality Disorder^a

^aAlgorithm based on clinical judgment that uses evidence currently in the literature, following the format of the International Psychopharmacology Algorithm Project (2). The first step in the algorithm is generally supported by the best empirical evidence. Recommendations may not be applicable to all patients or take individual needs into account. The empirical research studies on which these recommendations are based may be "first trials" involving previously untreated patients and may not take into account previous patient nonresponse to one, two, or even three levels of the algorithm (i.e., patients who, by definition, have more refractory disorders). There are no empirical trials of the complete algorithm.
^bSSRI treatment must be discontinued and followed with an adequate washout period before initiating treatment with an MAOI.
c

APPENDIX 3. Psychopharmacological Treatment of
Cognitive-Perceptual Symptoms in Patients With
Borderline Personality Disorder^a

^aAlgorithm based on clinical judgment that uses evidence currently in the literature, following the format of the International Psychopharmacology Algorithm Project (2). The first step in the algorithm is generally supported by the best empirical evidence. Recommendations may not be applicable to all patients or take individual needs into account. The empirical research studies on which these recommendations are based may be "first trials" involving previously untreated patients and may not take into account previous patient nonresponse to one, two, or even three levels of the algorithm (i.e., patients who, by definition, have more refractory disorders). There are no empirical trials of the complete algorithm.
^bThe generally favorable side effect profiles of the newer atypical neuroleptic medications compared with those of conventional neuroleptics underscore the need for careful empirical trials of these newer medications in the treatment of patients with borderline personality disorder.

AAPEL - Back to medication page
Warning:
All the informations on this site are with an aim of helping to understand a "particular" disease at the very least and puzzle
But more especially to support peoples who suffer, sick or not. In all cases, it is ESSENTIAL to have recourse to a therapist specialized in the disease to confirm or to cancel a diagnosis
Though it is the name doesn't much matter, which is important, it is to apply "the right" treatment to each patient